Delpharm Boucherville Canada
United Arab Emirates 228 employees Updated 9 July 2026
Delpharm Boucherville Canada is a finished-dose manufacturer based in United Arab Emirates. It appears in 5 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), NPRA (MY) and INVIMA (CO). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 26 January 2024 as VAI.
2
registered plants
1 with an FDA FEI number
5
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 26 January 2024 VAI US FDA
- 11 February 2020 NAI US FDA
- 12 June 2018 NAI US FDA
- 9 August 2016 NAI US FDA
- 22 October 2013 VAI US FDA
- 4 August 2011 OAI US FDA
- 15 July 2009 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Boucherville, United Arab Emirates | Not on file |
| Canada, Canada | 3000280957 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| EDE (AE) | 2 | None |
| NPRA (MY) | 2 | None |
| INVIMA (CO) | 1 | None |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Delpharm Boucherville Canada comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 26 January 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates